Schedule 13G ownership disclosure

Raptor Pharmaceutical Corp

Security class unavailable · CUSIP: 75382F106

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,445,000
Percent of class
5.5100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000897069-15-000296
Form type
SC 13G/A
Filer
Ivanishvili Bidzina
CIK
CIK 1608345
Filed
Apr 08, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub